April 21 (Reuters) - Noxopharm Ltd NOX.AX :
* TO SEEK APPROVAL FROM U.S. FDA FOR CLINICAL STUDY OF VEYONDA® IN COVID-19 PATIENTS
April 21 (Reuters) - Noxopharm Ltd NOX.AX :
* TO SEEK APPROVAL FROM U.S. FDA FOR CLINICAL STUDY OF VEYONDA® IN COVID-19 PATIENTS